Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120298) titled 'Efficacy Observation and Mechanism Study of Shouhui Tongbian Capsule in Regulating Intestinal Flora Metabolites to Attenuate the Progression of Renal Function in Chronic Kidney Disease Stages 3-5' on March 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Hospital of Nanjing University of Chinese Medicine
Condition:
Chronic Kidney Disease
Intervention:
Treatment Group:Basic Treatment + Shouhui Tongbian Capsule
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-03-11
Target Sample Size: Treatment Group:30;Control Group:30;
Countries of ...